| Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study |
|
Blood Advances |
Aplastic Anemia |
| Diagnosis and classification of myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Clinical decision-making and treatment of myelodysplastic syndromes |
|
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study |
|
Leukemia |
Aplastic Anemia |
| Morphologic Characteristics of Myelodysplastic Syndromes |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Transfusion Support of Patients with Myelodysplastic Syndromes |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53 |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
